Collapsing glomerulopathy in a patient with APOL1 intermediate-risk genotype triggered by lupus nephritis and SARS-CoV-2 infection: lessons for the clinical nephrologist

J Nephrol. 2022 Jan;35(1):347-350. doi: 10.1007/s40620-021-01144-5. Epub 2021 Sep 24.

Christophe Masset¹, Karine Renaudin^{2

3}, Delphine Kervella¹, Agnès Chapelet¹, Clément Deltombe¹, Simon Ville^{4

5}

¹ Department of Nephrology and Transplantation, Institut de Transplantation Urologie Néphrologie (ITUN), CHU de Nantes, 30 boulevard Jean Monnet, 44000, Nantes, France.
² Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France.
³ Department of Pathology, CHU Nantes, Nantes, France.
⁴ Department of Nephrology and Transplantation, Institut de Transplantation Urologie Néphrologie (ITUN), CHU de Nantes, 30 boulevard Jean Monnet, 44000, Nantes, France. simon.ville@chu-nantes.fr.
⁵ Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France. simon.ville@chu-nantes.fr.

No abstract available

Keywords: COVID-19-associated nephropathy; Collapsing glomerulopathy; Coronavirus disease 2019; Lupus nephritis; SARS-CoV-2.

Publication types